Viewing Study NCT04089657


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-29 @ 11:31 AM
Study NCT ID: NCT04089657
Status: UNKNOWN
Last Update Posted: 2019-09-13
First Post: 2019-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy Regimens
Sponsor: Fujian Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module